Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.

[1]  J. Kaye,et al.  Functional Analysis of B and T Lymphocyte Attenuator Engagement on CD4+ and CD8+ T Cells1 , 2005, The Journal of Immunology.

[2]  C. Benedict,et al.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Croft.  The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. , 2005, Trends in immunology.

[4]  Wenjun Ouyang,et al.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[6]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[7]  I. Ishikawa,et al.  Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. , 2004, Immunology letters.

[8]  J. Kaye,et al.  References Subscriptions Permissions Email Alerts An Inhibitory Ig Superfamily Protein Expressed by Lymphocytes and APCs Is Also an Early Marker of Thymocyte Positive Selection , 2013 .

[9]  Lieping Chen.  Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.

[10]  K. Murphy,et al.  Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. , 2003, Biochemical and biophysical research communications.

[11]  L. Lefrançois,et al.  IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion 1 , 2003, The Journal of Immunology.

[12]  Drew M Pardoll,et al.  Differential binding properties of B7-H1 and B7-DC to programmed death-1. , 2003, Biochemical and biophysical research communications.

[13]  T. Honjo,et al.  CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. , 2003, The Journal of rheumatology.

[14]  J. Allison,et al.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.

[15]  B. Carreno,et al.  Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation , 2003, Immunologic research.

[16]  S. Busfield,et al.  Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft Survival , 2002, The Journal of experimental medicine.

[17]  T. Yoshino,et al.  Expression of costimulatory CD80/CD86‐CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[19]  T. Honjo,et al.  PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. , 2001, Trends in immunology.

[20]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[21]  T. Tsukamoto,et al.  Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system. , 1999, Biochemical and biophysical research communications.

[22]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[23]  T. Inoue,et al.  Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. , 1999, Journal of immunology.

[24]  B. Kwon,et al.  LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. , 1998, The Journal of clinical investigation.

[25]  C. Ware,et al.  LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. , 1998, Immunity.

[26]  P. Linsley,et al.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.

[27]  L. Lanier,et al.  CD28- T lymphocytes. Antigenic and functional properties. , 1993, Journal of immunology.

[28]  P. Linsley,et al.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.

[29]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[30]  L. Lanier,et al.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. , 1992, Journal of immunology.

[31]  L. Lanier,et al.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.

[32]  M. Lefranc,et al.  Human Ig superfamily CTLA‐4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA‐4 cytoplasmic domains , 1988, European journal of immunology.